CIDOFOVIR ANHYDROUS

SynDRA canonical compound SYN0001885 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	DNA polymerase inhibitor
Indication	acquired immunodeficiency syndrome (AIDS) \| cytomegalovirus retinitis
Disease area	infectious disease

All known targets

cidofovir
cidofovir monophosphate
cidovir
vistide
sidofovir
cidofovir dihydrate
anhydrous cidofovir
cidofovir hydrate
Anhydrous cidofovir
Bbs-1067
Bmy-28167
Hpmpc
Cidofovir
CDV
Cidofovirum
Forvade
HPMPC
Vistide
GS-0504
GS-504
GS504
Cidofovir (Vistide)
Cidofovir (anhydrous)
Vistide (TN)
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
Cidofovir [INN]
Cidofovir hydrate
[1-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-propan-2-yl]oxymethylphosphonic acid
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine